In re Cipro Cases I & II

Outcome: The Court of Appeal affirmed the judgment for the defendants (Court of Appeal No. D056361).

Description: Class action plaintiffs alleged that a branded drug manufacturer and generic drug manufacturers violated antitrust laws by settling patent litigation challenging the branded drug manufacturer's patent on the active ingredient in the antibiotic Cipro.